Iranian Journal of Allergy, Asthma and Immunology 2017. 16(4):358-366.

Immunological Mechanisms Implicated in the Pathogenesis of Chronic Urticaria and Hashimoto Thyroiditis
Nicolae Ovidiu Berghi

Abstract


Autoimmunity represents the attack of the immune system of an organism against its own cells and tissues. Autoimmune diseases may affect one organ (Hashimoto thyroiditis) or can be systemic (chronic urticaria). Many factors are implicated in the pathogenesis of autoimmunity (white cells, cytokines, chemokines). Hashimoto thyroiditis has been associated with chronic urticaria in the last 3 decades in a number of clinical studies. Anti-thyroid antibodies have been documented in a proportion ranging from 10% to 30% in chronic urticaria patients in different countries from 3 continents. Two of the factors involved in the mechanism of autoimmunity are present both in the pathophysiology of Hashimoto thyroiditis and chronic urticaria. According to recent studies, IL6 is implicated in the pathogenesis of both diseases. TregsCD4+CD25+Foxp3+ cells have also been implicated in the pathological mechanisms of these 2 entities. This review offers an explanation of the clinical and statistical association between these two diseases from the pathophysiological point of view.


Keywords


CD 4+CD25+Tcells; Chronic urticaria; Hashimoto thyroiditis; Interleukin 6

Full Text:

PDF

References


1. Poletaev AB, Churilov LP, Stroev YI, Agapov MM. Immunophysiology versus immunopathology: Natural autoimmunity in human health and disease. Pathophysiology. 2012 Jun;19(3):221-31. doi: 10.1016/j.pathophys.2012.07.003. Epub 2012 Aug 9.

 

2. Edwards JC, Cambridge G. B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nat Rev Immunol. 2006 May;6(5):394-403. Review.

 

3. Kubach J, Becker C, Schmitt E, Steinbrink K, Huter E, Tuettenberg A, Jonuleit H. Dendritic cells: sentinels of immunity and tolerance. Int J Hematol. 2005 Apr;81(3):197-203. Review.

 

4. Srinivasan R, Houghton AN, Wolchok JD. Induction of autoantibodies against tyrosinase-related proteins following DNA vaccination: unexpected reactivity to a protein paralogue. Cancer Immun. 2002 Jul 19;2:8.

 

5. Green RS, Stone EL, Tenno M, Lehtonen E, Farquhar MG, Marth JD. Mammalian N-glycan branching protects against innate immune self-recognition and inflammation in autoimmune disease pathogenesis. Immunity. 2007 Aug;27(2):308-20. Epub 2007 Aug 2.

 

6. McGonagle D, McDermott MF.  A proposed classification of the immunological diseases. PLoS Med. 2006 Aug;3(8):e297.

 

7. Doble ND, Banga JP, Pope R, Lalor E, Kilduff P, McGregor AM. Autoantibodies to the thyroid microsomal/thyroid peroxidase antigen are polyclonal and directed to several distinct antigenic sites. Immunology. 1988 May;64(1):23-9.

 

8. Hiromatsu Y, Satoh H, Amino N. Hashimoto's thyroiditis: history and future outlook. Hormones (Athens). 2013 Jan-Mar;12(1):12-8. Review.

9. McLachlan SM, Rapoport B. Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity. Endocr Rev. 2014 Feb;35(1):59-105. Epub 2013 Dec 4. Review.

10. Swain M, Swain T, Mohanty BK. Autoimmune thyroid disorders-An update. Indian J Clin Biochem. 2005 Jan;20(1):9-17.

11. Pyzik A, Grywalska E, Matyjaszek-Matuszek B, Roliński J. Immune disorders in Hashimoto's thyroiditis: what do we know so far?  J Immunol Res. 2015;2015:979167. doi: 10.1155/2015/979167. Epub 2015 Apr 27. Review.

12. Popko K, Górska E. The role of natural killer cells in pathogenesis of autoimmune diseases. Cent Eur J Immunol. 2015;40(4):470-6. doi: 10.5114/ceji.2015.56971. Epub 2016 Jan 15. Review.

13. Dong YH, Fu DG. Autoimmune thyroid disease: mechanism,genetics and current knowledge. Eur Rev Med Pharmacol Sci. 2014;18(23):3611-8. Review.

14. Gora M, Dubska M, Jastrzebska-Bohaterewicz E, Gardas A. Profile of autoantibodies to the two immunodominant regions of thyroid peroxidase in autoimmunity. În Wiersinga WM, Drexhage HA, Weetman AP, Butz S (eds.), The thyroid and autoimmunity. Thieme Verlag, Stuttgart, 2007, 110-117.

15. Rho MH, Kim DW, Hong HP, Park YM, Kwon MJ, Jung SJ, Kim YW, Kang T. Diagnostic value of antithyroid peroxidase antibody for incidental autoimmune thyroiditis based on histopathologic results. Endocrine. 2012 Dec;42(3):647-52.  Epub 2012 May 12.

16. Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014 Apr-May;13(4-5):391-7. Epub 2014 Jan 13. Review.

17. Burek CL, Talor MV. Environmental triggers of autoimmune thyroiditis. JAutoimmun. 2009 Nov-Dec;33(3-4):183-9. Epub 2009 Oct 9.

18. Saboori AM, Rose NR, Bresler HS, Vladut-Talor M, Burek CL. Iodination of human thyroglobulin(Tg) alters its immunoreactivity. I. Iodination alters multiple epitopes of human Tg.Clin.Exp.Immunol 1998;113:297–302.

19. Saboori AM, Rose NR, Burek CL. Iodination of human thyroglobulin (Tg) alters its immunoreactivity.II. Fine specificity of a monoclonal antibody that recognizes iodinated Tg. Clin.Exp.Immunol 1998;113:303–308.

20. Rasooly L, Rose NR, Saboori AM, Ladenson PW, Burek CL. Iodine is essential for human T cell recognition of human thyroglobulin. Autoimmunity 1998;27:213–219.

21. Carayanniotis G. Molecular parameters linking thyroglobulin iodination with autoimmune thyroiditis. Hormones (Athens). 2011 Jan-Mar;10(1):27-35. Review.

 22. Li HS, Jiang HY, Carayanniotis G. Modifying effects of iodine on the immunogenicity of thyroglobulin peptides. J Autoimmun. 2007 Jun;28(4):171-6. Epub 2007 Feb 26.

 

23. Czarnocka B. Thyroperoxidase, thyroglobulin, Na(+)/I(-) symporter, pendrin in thyroid autoimmunity. Front Biosci., 2011, Jan 1; 16: 783-802.

24. Yoshida A, Hisatome I, Taniguchi S, Shirayoshi Y, Yamamoto Y, Miake J, Ohkura T, Akama T, Igawa O, Shigemasa C, Kamijo K, Ikuyama S, Caturegli P, Suzuki K. Pendrin is a novel autoantigen recognized by patients with autoimmune thyroid diseases. J Clin Endocrinol Metab. 2009 Feb;94(2):442-8. Epub 2008 Dec 2.

25. Yoneda M, Fujii A, Ito A, Yokoyama H, Nakagawa H, Kuriyama M. High prevalence of serum autoantibodies against the amino terminal of alpha-enolase in Hashimoto's encephalopathy. J Neuroimmunol. 2007 Apr;185(1-2):195-200. Epub 2007 Mar 1.

26. Weetman AP. The immunopathogenesis of chronic autoimmune thyroiditis one century after hashimoto. Eur Thyroid J. 2013 Jan;1(4):243-50. Epub 2012 Nov 2. Review.

27.  Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune thyroid disorders. Autoimmun Rev. 2015 Feb;14(2):174-80. Epub 2014 Oct 25. Review.

28. Yang X, Gao T, Shi R, Zhou X, Qu J, Xu J, Shan Z, Teng W. Effect of iodine excess on Th1, Th2, Th17, and Treg cell subpopulations in the thyroid of NOD.H-2h4 mice. Biol Trace Elem Res. 2014 Jun;159(1-3):288-96. Epub 2014 Apr 17.

29. Cui SL, Yu J, Shoujun L.. Iodine Intake Increases IP-10 Expression in the Serum and Thyroids of Rats with Experimental Autoimmune Thyroiditis. Int J Endocrinol. 2014;2014. Epub 2014 Feb 25.

30. Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy. 2014;69:868–87

31. Powell RJ, Leech SC, Till S, Huber PA, Nasser SM, Clark AT. BSACI guideline for the management of chronic urticaria and angioedema. Clin Exp Allergy. 2015 Mar;45(3):547-65.

32. Greaves MW. Chronic idiopatic urticaria. Cur Opin Allergy Clin Immunol 2003;3:363-8

33. Wardhana, Datau EA. Chronic autoimmune urticaria. Acta Med Indones. 2012 Apr;44(2):165-74.

34. Viegas LP, Ferreira MB, Kaplan AP. The maddening itch: an approach to chronic urticaria. J Investig Allergol Clin Immunol. 2014;24(1):1-5. Review.

 35. Jain S. Pathogenesis of chronic urticaria: an overview. Dermatol Res Pract. 2014;2014. Epub 2014 Jul 10. Review.

36. Konstantinou GN, Asero R, Ferrer M, Knol EF, Maurer M, Raap U, Schmid-Grendelmeier P, Skov PS, Grattan CE. EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria. Allergy. 2013 Jan;68(1):27-36. Epub 2012 Nov 15.

37. Ferrer M. Immunological events in chronic spontaneous urticaria. Clin Transl Allergy. 2015 Aug 25;5:30. eCollection 2015. Review.

38. Altman K, Chang C. Pathogenic intracellular and autoimmune mechanisms in urticaria and angioedema. Clin Rev Allergy Immunol. 2013 Aug;45(1):47-62.  Review.

39. Pan XF, Gu JQ, Shan ZY. The prevalence of thyroid autoimmunity in patients with urticaria: a systematic review and meta-analysis. Endocrine. 2015 Apr;48(3):804-10.  Epub 2014 Jul 27.

40. Leznoff A, Josse RG, Denburg J, Dolovich J. Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol. 1983 Aug;119(8):636-40.

41. Leznoff A, Sussman GL. Symdrome of idiophatic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patents. J Allergy Clin Immunol. 1989 Jul;84(1):66-71.

42. Turktas I, Gokcora N, Demirsoy S, Cakir N, Onal E. The association of chronic urticaria and angioedema with autoimmune thyroiditis. Int J Dermatol. 1997 Mar;36(3):187-90.

43. Zauli D, Deleonardi G, Foderaro S, Grassi A, Bortolotti R, Ballardini G, Bianchi FB. Thyroid autoimmunity in chronic urticaria. Allergy Asthma Proc. 2001 Mar-Apr;22(2):93-5.

44. Kullavanijaya P, Puavilai G, Puavilai S, Chanprasertyothin S. Prevalence of thyroid antibodies in Thai patients with chronic idiopathic urticaria. J Med Assoc Thai. 2002 Aug;85(8):901-6.

45. Jiménez Saab NG, Goméz Vera J, López Tiro JJ, Salas Pérez G, López Islas I, Pliego Reyes CL. Prevalence of chronic urticaria of autoimmune origin at the Regional Hospital Adolfo Lopez Mateos. Rev Alerg Mex. 2006 Mar-Apr;53(2):58-63. Spanish.

46. Cebeci F, Tanrikut A, Topcu E, Onsun N, Kurtulmus N, Uras AR. Association between chronic urticaria and thyroid autoimmunity. Eur J Dermatol. 2006 Jul-Aug;16(4):402-5.

47. Aamir IS, Tauheed S, Majeed F, Atif A. Serum antithyroid antibodies in female patients with chronic urticaria. J Coll Physicians Surg Pak. 2008 Aug;18(8):498-501.

48. Nuzzo V, Tauchmanova L, Colasanti P, Zuccoli A, Colao A. Idiopathic chronic urticaria and thyroid autoimmunity: Experience of a single center. Dermatoendocrinol. 2011 Oct;3(4):255-8. Epub 2011 Oct 1.

49. Irani C, Jammal M, Asmar G, Hajj H, Halaby G. Chronic urticaria and autoimmune thyroiditis. J Med Liban. 2012 Apr-Jun;60(2):88-90.

50. Missaka RF, Penatti HC, Silvares MR, Nogueira CR, Mazeto GM. Autoimmune thyroid disease as a risk factor for angioedema in patients with chronic idiopathic urticaria: a case-control study. Sao Paulo Med J. 2012;130(5):294-8.

51. Sugiyama A, Nishie H, Takeuchi S, Yoshinari M, Furue M. Hashimoto's disease is a frequent comorbidity and an exacerbating factor of chronic spontaneous urticaria. Allergol Immunopathol (Madr). 2015 May-Jun;43(3):249-53. Epub 2014 Aug 1.

52. Bumbacea RS, Popa LG, Orzan OA, Voiculescu VM, Giurcaneanu C. Clinical and Therapeutic Implications of the Association between Chronic Urticaria and Autoimmune Thyroiditis. Acta Endo (Buc) 2014 10: 595-604.

53. Confino-Cohen R, Chodick G, Shalev V, Leshno M, Kimhi O, Goldberg A. Chronic urticaria and autoimmunity: associations found in a large population study. J Allergy Clin Immunol. 2012 May;129(5):1307-13. Epub 2012 Feb 14.

54. Kasperska-Zajac A, Sztylc J, Machura E, Jop G.  Plasma IL-6 concentration correlates with clinical disease activity and serum C-reactive protein concentration in chronic urticaria patients. Clin Exp Allergy. 2011 Oct;41(10):1386-91. Epub 2011 Jun 6.

55. Kasperska-Zajac A. Acute-phase response in chronic urticaria. J Eur Acad Dermatol Venereol. 2012 Jun;26(6):665-72. Epub 2011 Nov 25. Review.

56. Kasperska-Zajac A, Jasinska T, Grzanka A, Kowalik-Sztylc A. Markers of systemic inflammation in delayed pressure urticaria. Int J Dermatol. 2013 Mar;52(3):309-10. Epub 2012 Nov 1.

57. Lin P. Targeting interleukin-6 for noninfectious uveitis. Clin Ophthalmol. 2015 Sep 11;9:1697-702. eCollection 2015. Review.

58. Tanaka T, Kishimoto T. The biology and medical implications of interleukin-6. Cancer Immunol Res. 2014 Apr;2(4):288-94. Review.

59. Kasperska-Zajac A, Brzoza Z, Rogala B. Plasma concentration of interleukin 6 (IL-6), and its relationship with circulating concentration of dehydroepiandrosterone sulfate (DHEA-S) in patients with chronic idiopathic urticaria. Cytokine. 2007 Aug;39(2):142-6. Epub 2007 Sep 10.

60. Rasool R, Ashiq I, Shera IA, Yousuf Q, Shah ZA. Study of serum interleukin (IL) 18 and IL-6 levels in relation with the clinical disease severity in chronic idiopathic urticaria patients of Kashmir (North India). Asia Pac Allergy. 2014 Oct;4(4):206-11. Epub 2014 Oct 29.

61. Lawlor F, Bird C, Camp RD, et al. Increased interleukin6, but reduced interleukin 1, in delayed pressure urticaria. Br J Dermatol 1993; 128: 500–503.

62. Bai X, Sun J, Wang W, Shan Z, Zheng H, Li Y, Zhao Y, Gong M, Teng W. Increased differentiation of Th22 cells in Hashimoto,s thyroiditis. Endocr J. 2014;61(12):1181-90. Epub 2014 Sep 20.

 

63.  Khan FA, Al-Jameil N, Khan MF, Al-Rashid M, Tabassum H. Thyroid dysfunction: an autoimmune aspect. Int J Clin Exp Med. 2015 May 15;8(5):6677-81. eCollection 2015. Review.

64. Boutzios G, Kaltsas G. Immune System Effects on the Endocrine System. In: De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, Rebar R, Singer F, Vinik A, Weickert MO, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-2015 Mar 28.

65. Mellanby RJ, Thomas DC, Lamb J. Role of regulatory T-cells in autoimmunity. Clin Sci (Lond). 2009 Apr;116(8):639-49. Review.

66. Eisenstein EM, Williams CB. The T(reg)/Th17 cell balance: a new paradigm for autoimmunity. Pediatr Res. 2009 May;65(5 Pt 2):26R-31R. Review.

67. Valencia X, Lipsky PE. CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases. Nat Clin Pract Rheumatol. 2007 Nov;3(11):619-26. Review.

68. Abdulahad WH, Boots AM, Kallenberg CG. FoxP3+ CD4+ T cells in systemic autoimmune diseases: the delicate balance between true regulatory T cells and effector Th-17 cells. Rheumatology (Oxford). 2011 Apr;50(4):646-56. Epub 2010 Oct 28. Review.

69. Arshi S, Babaie D, Nabavi M, Tebianian M, Ghalehbaghi B, Jalali F, Ahmadvand A, Gholami R. Circulating level of CD4+ CD25+ FOXP3+ T cells in patients with chronic urticaria. Int J Dermatol. 2014 Dec;53(12):e561-6. Epub 2014 Oct 14.

70. Sun RS, Sui JF, Chen XH, Ran XZ, Yang ZF, Guan WD, Yang T. Detection of CD4+ CD25+ FOXP3+ regulatory T cells in peripheral blood of patients with chronic autoimmune urticaria. Australas J Dermatol. 2011 Aug;52(3):e15-8. Epub 2010 Jun 28.

71. Chen WC, Chiang BL, Liu HE, Leu SJ, Lee YL. Defective functions of circulating CD4+CD25+ and CD4+CD25- T cells in patients with chronic ordinary urticaria. J Dermatol Sci. 2008 Aug;51(2):121-30. Epub 2008 Apr 28.

72. Xue H, Wang W, Shan Z, Li Y, Li Y, Teng X, Gao Y, Fan C, Teng W. Dynamic changes of CD4+CD25 + regulatory T cells in NOD.H-2h4 mice with iodine-induced autoimmune thyroiditis. Biol Trace Elem Res. 2011 Oct;143(1):292-301. Epub 2010 Sep 7.

73. Glick AB, Wodzinski A, Fu P, Levine AD, Wald DN. Impairment of regulatory T-cell function in autoimmune thyroid disease. Thyroid. 2013 Jul;23(7):871-8.

74. Xue H, Yu X, Ma L, Song S, Li Y, Zhang L, Yang T, Liu H. The possible role of CD4(+)CD25(high)Foxp3(+)/CD4(+)IL-17A(+) cell imbalance in the autoimmunity of patients with Hashimoto thyroiditis. Endocrine. 2015 Dec;50(3):665-73. Epub 2015 Mar 13.


Refbacks

  • There are currently no refbacks.


Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.